Durability of infliximab shapiro et al
WebMar 1, 2014 · A retrospective cohort study included 93 patients (216.3 patient-years) treated with infliximab for psoriasis. Kaplan-Meier analysis assessed drug durability. Results A … WebAt week 14, 91 patients (49.1%) in the TDM group and 104 patients (54.7%) in the standard therapy group had attained clinical remission (adjusted difference, 6%; 95% CI, −3.7% to …
Durability of infliximab shapiro et al
Did you know?
WebJun 12, 2024 · A previous randomized, double-blind, placebo-controlled, proof-of-concept clinical trial evaluating the antidepressant efficacy of infliximab, a tumor necrosis factor … WebThe mean follow-up time with infliximab treatment was 41 months, and the majority (95%) were on concomitant immunosuppressive therapy. The annual risk of loss of response to …
WebJun 1, 2016 · Durability of Infliximab Is Associated With Disease Extent in Children With Inflammatory Bowel Disease. 1 Europe PMC requires Javascript to function effectively. WebObjectives: To assess the efficacy of infliximab in sarcoidosis. Methods: A phase 2, multicenter, randomized, double-blind, placebo …
WebDec 30, 2013 · Infliximab often requires dose escalation to maintain response. Studies regarding long-term durability and dose escalation patterns for psoriasis are few. We sought to evaluate dose escalation... WebInfliximab antibodies developed in 4.5% of the patients in the active treatment group. Conclusion Treatment with infliximab for up to 6 months is effective for arthritis, …
WebJan 28, 2014 · Median week 14 trough levels of patients with and without durable sustained response to infliximab 5 mg/kg were 4.0 and 1.9 μg/mL, respectively (p=0.0331). ... Arias et al 11 reported that median early postinduction serum infliximab trough levels were higher in patients with ulcerative colitis receiving combined infliximab and immunomodulator ...
WebWe evaluated LOR to biologics in our Crohn disease (CD) patients receiving biologics. Of 137 biologic-treated CD patients, 68 continuously receiving the same biologic type for at … aleppo clown unitWebMar 1, 2014 · A.B. Gottlieb et al. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol ... M. Chaparro et al. Long-term durability of infliximab treatment in Crohn’s disease and efficacy of dose “escalation” in patients losing response. J Clin ... aleppo cnnWebNov 17, 2011 · Fourteen patients (46.7%) eventually lost response to dose intensification; however, dose intensification extended infliximab therapy by a median duration of 9 months (interquartile range 6–17 months). Of these 14 patients, four (31%) experienced an adverse event which led to discontinuation of infliximab. aleppo claimWebJan 2, 2014 · The mean (±SD) age at initiation of infliximab therapy was 50.2 ± 15.6 years (range: 16-80 years), with 45 female patients (48.4%). Fifty-nine patients (63.4%) had coexisting psoriatic arthritis and 33 … aleppo cat man donateWebApr 1, 2014 · Lin KK, Velayos F, Fisher E, et al. Durability of infliximab dose intensification in Crohn’s disease. Dig Dis Sci. 2012; 57:1013–1019. [Google Scholar] 10. Chaparro M, Panes J, Garcia V, et al. Long-term durability of infliximab treatment in Crohn’s disease and efficacy of dose “escalation” in patients losing response. J Clin ... aleppo climateWebSep 26, 2024 · A retrospective analysis of patients with inflammatory bowel disease who received proactive vs reactive monitoring of infliximab serum concentrations showed that proactive drug monitoring was associated with greater drug durability, less need for inflammatory bowel disease–related surgery or hospitalization, and lower risk of … aleppo controlWebThe difference in time to discontinuation at 52 months of follow-up between the infliximab and adalimumab subgroups, as either first- or second-line treatment, was not statistically … aleppo colors